Thursday

Home > Blog > Thursday

Tag: Thursday

By

Postpartum Depression & Anxiety: How to Identify & Treat Struggling Parents

Speaker(s):

Beth Orns, MSW, LCSW

Abby Underwood, MSW, LCSW

Francesca Tocco, MSW, LCSW

Presentation: This presentation will provide information about postpartum mental health issues. Information on evidence-based assessment tools will be provided. In addition to ensuring participants understand postpartum mental health issues we will discuss strategies for support. We will also provide information about a support group we facilitate for parents with Postpartum Depression or Anxiety. We will share lessons we have learned from our experience with this group and provide information on how to facilitate a support group in your community.

Objectives:

  1. Deliver an understanding of postpartum mental health issues
  2. Increase comfort in assessing and addressing postpartum mental health issues in practice
  3. Provide a road map for how to provide a support group for postpartum mental health issues in your community

Orns_PPDownload
By

Kattula, Ambika, MD

Kattula is a second-year resident psychiatrist at University of Missouri Kansas City, in Kansas City, Missouri. Kattula completed a medical degree from Andhra Medical College in India. After practicing medicine in India, she moved to USA with her family. She worked as a clinical observer at various hospitals in Iowa including University of Iowa, Trinity Health Care and Mercy Care, and also at St. Mary’s hospital in Connecticut. Along with familiarizing the US clinical system, she pursued an interest in research at University of Iowa in the area of prostate cancer research in the lab of Dr. David Lubaroff. Later, due to her interest in psychiatry, she joined Dr. John Wemmie’s lab in the Department of Psychiatry at the University of Iowa where her focus was the utilization of proton exchange MRI to study metabolic abnormalities in the brain. Kattula’s research works were culminated in poster presentations and publications.

During Kattula’s residency at UMKC, she has been receiving rigorous training in managing patients of ages ranging from 18 to 60 with wide variety of psychological disorders of varying severity. During her first year, she presented a poster on the topic of “managing psychiatric/behavioral problems in a patient with chromosome 18 deletion syndrome” in American Psychiatry Association Meeting-2018, New York City, NY along with coauthoring 2 other posters. Recently, her abstract regarding Cognitive Enhancement Therapy in real-world schizophrenia population got accepted for American Psychiatry Association meeting that will be held in May, 2019.

Presentation(s): 

Substance-Induced Neurocognitive Disorder

By

Substance-Induced Neurocognitive Disorder

Speaker(s):

Ambika Kattula, MD

Presentation: Ms. T is a 27-year-old Caucasian female with a past medical history of bipolar disorder with psychotic features, methamphetamine use disorder and cannabis use disorder admitted to our forensic inpatient unit after she was found incompetent to stand trial on charges of burglary and stealing related offense. She was misusing multiple substances including methamphetamine, marijuana, inhalants, opioids and benzodiazepines on daily basis for several years starting at the age of 18 until incarceration a few months before the current admission. Her main presenting symptoms including mood symptoms and anxiety were well controlled during first month of hospitalization with medication regimen of oral valproic acid 1000mg at bed time for mood stabilization and oral paliperidone 6mg daily for psychosis. However, cognitive deficits of memory and attention became apparent gradually. Psychology testing demonstrated impairment in multiple cognitive domains. Medical diagnoses as cause of cognitive impairment were excluded with the help of laboratory testing and MRI brain. She was finally given diagnosis of Substance/Medication-Induced Major Neurocognitive Disorder. This presentation gives an overview of this case followed by discussion of diagnostic criteria and risk factors of substance induced neurocognitive disorder with a brief view of cognitive deficits due to few specific substances, consequences of cognitive impairment and lastly, therapeutic strategies.

Objectives:

  1. Review DSM 5 criteria for Substance/Medication-Induced Major Neurocognitive Disorder
  2. Identify risk factors for Substance/Medication-Induced Major Neurocognitive Disorder
  3. Describe cognitive deficits caused by few commonly misused substances
  4. Identify feasible therapeutic strategies that can be acquired to help patients

Kattula_PPDownload
By

Bin Mahfodh, Abdullah, MD

Abdullah Bin Mahfodh M.D. is a psychiatry resident at the University of Missouri- Kansas City. Dr. Bin Mahfodh obtained his medical degree from Jordan University of Science and Technology, soon after, he traveled to the United States and started to pursue his dream of becoming a psychiatrist. He is planning to complete a fellowship in child and adolescent psychiatry.

Presentation(s): 

Over the Counter Drug of Abuse: Dextromethorphan

By

Godfroy, Eric

Eric was first drawn to serve individuals experiencing homelessness in South Korea during 2006. After returning to the US in 2008 he began working as a community support specialist at Assertive Community Outreach, providing direct care to those experiencing homelessness, severe mental illnesses, and substance use disorders. His current position with the Assertive Community Outreach / PATH team focuses on increasing access to mainstream benefits and SOAR. This position affords Eric the opportunity to foster connections with social service providers and to encourage others to demand social justice for the most marginalized and disenfranchised in society.

Presentation(s): 

SOAR can work for YOU! How SOAR can Improve Engagement, Outcomes & Community Alliances

By

Reck, Jared, BA

Jared earned his B.A. in psychology in 2013 through the University of Central Missouri and was quickly hired as a Recovery Coach with Truman Medical Center. Through his own curiosity and interest in serving his clients well, Jared discovered the benefits of using SOAR to assist those experiencing severe mental illness and homelessness. In 2017 he was asked to join the Assertive Community Outreach/PATH team, where he would focus on benefits and engagement for Jackson County’s most vulnerable. Jared is committed to fostering a community that embraces housing, income, compassionate connection, and respect as basic human rights.

Presentation(s): 

SOAR can work for YOU! How SOAR can Improve Engagement, Outcomes & Community Alliances

By

Schwab, Sara, MS, LPC

Sara Schwab is a Licensed Professional Counselor and is the Team Leader and PATH Project Director for Truman Behavioral Health Assertive Community Outreach. Since 2006 she has worked in community mental health and specifically with individuals experiencing homelessness and mental illness since 2011. Her work has been as a case manager counselor, intake therapist, and outreach coordinator. Her current position includes clinical oversight for outreach and therapy services as well as direct client care and the supervision of the allocation of grant monies. Sara is committed to ending chronic homelessness, particularly as it relates to those experiencing mental illness.

Presentation(s): 

SOAR can work for YOU! How SOAR can Improve Engagement, Outcomes & Community Alliances

Housing First

By

SOAR can work for YOU! How SOAR can Improve Engagement, Outcomes & Community Alliances

Speaker(s):

Sara Schwab, MS, LPC

Jared Reck, BA

Eric Godfroy

Presentation: SOAR is used throughout Missouri to assist individuals experiencing SMI and homelessness with accessing financial benefits, but the reach of SOAR expands far greater than increasing clients’ income. By developing a consistent practice for utilizing SOAR in local communities, providers will see improvements in client engagement and retention, improved outcomes at the client and program level, and strengthened partnerships with agencies, leading to a more collaborative and coordinated system. This presentation provides an overview of the SSI/SSDI Outreach, Access, and Recovery (SOAR) process in both theory and practice. Strategies for working with challenging circumstances (substance use disorders, initial episodes, institutional barriers) will be discussed and attendees will have an opportunity to talk through barriers that they have experienced when establishing or maintaining a SOAR program. The benefits of maintaining traction through those challenges are impactful to clients, providers, and the local community and each of those areas will be covered in detail.

Objectives:

  1. Describe the SOAR process in Missouri
  2. Utilize specific strategies for working with challenging circumstances during the SOAR process
  3. Identify several benefits of using SOAR at the client, program, and community levels

Schwab_SOAR_PPDownload
By

Suicide Risk Assessment: A Review of Risk Factors for Suicide in Bipolar Disorder

Speaker(s):

Anchana Dominic, MD

Presentation: In 2016, 45,000 Americans lost their lives to suicide (CDC Data). Since 1999, suicide rates have gone up by more than 30%. Mental illness is a known contributing factor to suicide. In clinical samples, about 50% of individuals with bipolar disorder were found to have a history of a suicide attempt. The rate of suicide attempts in those with bipolar disorder was twice that of individuals with unipolar depression. In this presentation, Dr. Dominic will review empirically researched risk factors associated with suicide in individuals with bipolar disorder. Specific symptoms and clinical presentations associated with risk of suicide will be discussed. Some of the risk factors include family history of suicide, early onset of bipolar disorder, rapid cycling, and abuse of alcohol and/or drugs. Dr. Dominic will discuss how to evaluate for these risk factors and the clinical application to preventing suicide in this population.

Objectives:

  1. Explain the prevalence of suicide in bipolar disorder
  2. Identify risk factors for suicide in bipolar disorder
  3. Describe how to assess for risk factors in bipolar disorder

Dominic_PPDownload